The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Porphyria
Abstract
Each of the eight enzymes involved in porphyrin synthesis can be defective and can produce a distinctive form of porphyria. The diagnosis of porphyria can be obscure and the symptoms severe. New treatments are emerging to manage the wide constellation of symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Lyons, J. S., & Mieler, W. F. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.11.017 · Cited by 710
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Anderson, K. E., Bloomer, J. R., Bonkovsky, H. L., Kushner, J. P., Pierach, C. A., Pimstone, N. R., & Desnick, R. J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00010 · Cited by 628
Self-citationWhatley, S. D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M. N., Elder, G. H., Holme, S. A., Anstey, A. V., Parker, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.003 · Cited by 293
The incidence of inherited porphyrias in Europe
Elder, G., Harper, P., Badminton, M., Sandberg, S., & Deybach, J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9544-4 · Cited by 292
Afamelanotide for Erythropoietic Protoporphyria
Langendonk, J. G., Balwani, M., Anderson, K. E., Bonkovsky, H. L., Anstey, A. V., Bissell, D. M., Bloomer, J., Edwards, C., Neumann, N. J., Parker, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411481 · Cited by 283
Self-citationPorphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america†
Bonkovsky, H. L., Poh-Fitzpatrick, M., Pimstone, N., Obando, J., Di Bisceglie, A., Tattrie, C., Tortorelli, K., LeClair, P., Mercurio, M. G., & Lambrecht, R. W. (1998) · Hepatology · doi:10.1002/hep.510270627 · Cited by 270
Self-citationZinc Protoporphyrin: A Metabolite with a Mission
Labbé, R. F., Vreman, H. J., & Stevenson, D. K. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.12.2060 · Cited by 270
Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium
Bonkovsky, H. L., Maddukuri, V. C., Yazici, C., Anderson, K. E., Bissell, D. M., Bloomer, J. R., Phillips, J. D., Naik, H., Peter, I., Baillargeon, G., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.06.036 · Cited by 264
Self-citationAcute Porphyrias: Pathogenesis of Neurological Manifestations
Meyer, U., Schuurmans, M., & Lindberg, R. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007139 · Cited by 231
δ-Aminolaevulinic acid is a potent agonist for GABA autoreceptors
BRENNAN, M. J. W., & CANTRILL, R. C. (1979) · Nature · doi:10.1038/280514a0 · Cited by 215
A Plasma Porphyrin Fluorescence Marker for Variegate Porphyria
Poh‐Fitzpatrick, M. B. (1980) · Archives of Dermatology · doi:10.1001/archderm.116.5.543 · Cited by 169
Chen, B., Solis-Villa, C., Hakenberg, J., Qiao, W., Srinivasan, R. R., Yasuda, M., Balwani, M., Doheny, D., Peter, I., Chen, R., et al. (2016) · Human Mutation · doi:10.1002/humu.23067 · Cited by 167
Liver transplantation for erythropoietic protoporphyria liver disease
McGuire, B. M., Bonkovsky, H. L., Carithers, R. L., Chung, R. T., Goldstein, L. I., Lake, J. R., Lok, A. S., Potter, C. J., Rand, E., Voigt, M. D., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20620 · Cited by 163
Self-citationA porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
Phillips, J. D., Bergonia, H. A., Reilly, C. A., Franklin, M. R., & Kushner, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700547104 · Cited by 160
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
D’Avola, D., López‐Franco, E., Sangro, B., Pañeda, A., Grosios, N., Gil-Fariña, I., Benito, A., Twisk, J., Paz, M., Ruiz, J. A., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.012 · Cited by 144
NORDMANN, Y., Puy, H., Silva, V. D., Simonin, S., Robréau, A.-M., Bonaïti‐Pellié, C., Phung, L., & Deybach, J. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00189.x · Cited by 139
Yasuda, M., Gan, L., Chen, B., Kadirvel, S., Yu, C., Phillips, J. D., New, M. I., Liebow, A., Fitzgerald, K. J., Querbes, W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406228111 · Cited by 133
Liver transplantation in the management of porphyria
Singal, A. K., Parker, C., Bowden, C., Thapar, M., Liu, L., & McGuire, B. M. (2014) · Hepatology · doi:10.1002/hep.27086 · Cited by 132
Chan, A., Liebow, A., Yasuda, M., Gan, L., Racie, T., Maier, M., Kuchimanchi, S., Foster, D., Milstein, S., Charisse, K., et al. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.36 · Cited by 128
Genetic aspects of erythropoietic protoporphyria
Went, L. N., & Klasen, E. C. (1984) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1984.tb01006.x · Cited by 128
Pallet, N., Mami, I., Schmitt, C., Karim, Z., François, A., Rabant, M., Nochy, D., Gouya, L., Deybach, J., Xu-Dubois, Y., et al. (2015) · Kidney International · doi:10.1038/ki.2015.97 · Cited by 127
Dowman, J. K., Gunson, B. K., Mirza, D. F., Bramhall, S. R., Badminton, M. N., & Newsome, P. N. (2011) · Liver Transplantation · doi:10.1002/lt.22345 · Cited by 112
Singal, A. K., Kormos–Hallberg, C., Lee, C., Sadagoparamanujam, V. M., Grady, J. J., Freeman, D. H., & Anderson, K. E. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.038 · Cited by 110
Self-citationLong-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria
Biolcati, G., Marchesini, E., Sorge, F., Barbieri, L., Schneider‐Yin, X., & Minder, E. I. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13598 · Cited by 108
Xu, W., Warner, C. A., & Desnick, R. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117742 · Cited by 102
Balwani, M., Doheny, D. O., Bishop, D. F., Nazarenko, I. A., Yasuda, M., Dailey, H. A., Anderson, K. E., Bissell, D. M., Bloomer, J. R., Bonkovsky, H. L., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00340 · Cited by 101
Self-citationRole of Delta-aminolevulinic Acid in the Symptoms of Acute Porphyria
Bissell, D. M., Lai, J. C., Meister, R., & Blanc, P. D. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.10.026 · Cited by 99
Self-citationNaik, H., Stoecker, M., Sanderson, S. C., Balwani, M., & Desnick, R. J. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.08.006 · Cited by 88
Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo
Biessen, E. A. L., Vietsch, H., Rump, E. T., Fluiter, K., Kuiper, J., Bijsterbosch, M. K., & van Berkel, T. J. C. (1999) · Biochemical Journal · doi:10.1042/bj3400783 · Cited by 82
Associations Among Behavior-Related Susceptibility Factors in Porphyria Cutanea Tarda
Jalil, S., Grady, J. J., Lee, C., & Anderson, K. E. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.11.017 · Cited by 76
Self-citationInnala, E., Bäckström, T. C., Bixo, M., & Andersson, C. (2009) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903390729 · Cited by 69
A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease
Tchernitchko, D., Tavernier, Q., Lamoril, J., Schmitt, C., Talbi, N., Lyoumi, S., Robréau, A.-M., Karim, Z., Gouya, L., Thervet, É., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080918 · Cited by 69
Instability of Hematin Used in the Treatment of Acute Hepatic Porphyria
Goetsch, C. A., & Bissell, D. M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150406 · Cited by 65
Self-citationYasuda, M., Bishop, D. F., Fowkes, M. E., Cheng, S. H., Gan, L., & Desnick, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.250 · Cited by 60
CYP1A2 Is Essential in Murine Uroporphyria Caused by Hexachlorobenzene and Iron
Sinclair, P. R., Gorman, N., Walton, H. S., Bement, W. J., Dalton, T. P., Sinclair, J. F., Smith, A. G., & Nebert, D. W. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8832 · Cited by 57
Grand mal seizures and acute intermittent porphyria
MAGNUSSEN, C. R., Doherty, J. M., Hess, R. A., et al. (1975) · Neurology · doi:10.1212/wnl.25.12.1121 · Cited by 54
Willandt, B., Langendonk, J. G., Biermann, K., Meersseman, W., D’Heygere, F., George, C., Verslype, C., Monbaliu, D. R. L., & Cassiman, D. M. (2015) · JIMD Reports · doi:10.1007/8904_2015_458 · Cited by 51
Bulaj, Z. J., Franklin, M. R., Phillips, J. D., Miller, K. L., Bergonia, H. A., Ajioka, R. S., Griffen, L. M., Guinee, D. J., Edwards, C. Q., & Kushner, J. P. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.111024 · Cited by 50
Cox, T. M., Alexander, G., & SARKANY, R. P. E. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007144 · Cited by 47
Antioxidant β-Carotene Does Not Quench Singlet Oxygen in Mammalian Cells
Bosio, G. N., Breitenbach, T., Parisi, J. M., Reigosa, M. A., Blaikie, F. H., Pedersen, B. W., Silva, E. F. F., Mártire, D. O., & Ogilby, P. R. (2012) · Journal of the American Chemical Society · doi:10.1021/ja308930a · Cited by 45
Bonkovsky, H. L., Siao, P., Roig, Z., Hedley‐Whyte, E. T., & Flotte, T. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmcpc0803190 · Cited by 43
Self-citationPitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias
Gou, E., Balwani, M., Bissell, D. M., Bloomer, J. R., Bonkovsky, H. L., Desnick, R. J., Naik, H., Phillips, J. D., Singal, A. K., Wang, B., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.245456 · Cited by 41
Self-citationGroß, U., Sassa, S., Jacob, K., Deybach, J., NORDMANN, Y., Frank, M., & Manfred Otto, D. O. S. S. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.9.1892 · Cited by 40
Vitamin D deficiency in patients with erythropoietic protoporphyria
Spelt, J. M. C., de Rooij, F. W. M., Wilson, J. H. P., & Zandbergen, A. A. M. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1037-0 · Cited by 35
Nakano, H., Nakano, A., Toyomaki, Y., Ohashi, S., Harada, K., Moritsugu, R., Takeda, H., Kawada, A., Mitsuhashi, Y., & Hanada, K. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700456 · Cited by 31
Nonsteroidal Antiinflammatory Drug-Induced Pseudoporphyria: A Case Series
LaDuca, J. R., Bouman, P. H., & Gaspari, A. A. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0051-8 · Cited by 28
Homeostasis of iron and hepcidin in erythropoietic protoporphyria
Bossi, K. L., Lee, J., Schmeltzer, P. A., Holburton, E., Groseclose, G., Besur, S. V., Hwang, S., & Bonkovsky, H. L. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12503 · Cited by 28
Self-citationCYP1A2*1F and GSTM1 Alleles Are Associated with Susceptibility to Porphyria Cutanea Tarda
Wickliffe, J. K., Abdel‐Rahman, S. Z., Lee, C., Kormos–Hallberg, C., Sood, G., Rondelli, C. M., Grady, J. J., Desnick, R. J., & Anderson, K. E. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00130 · Cited by 21
Self-citationDeferasirox for Porphyria Cutanea Tarda: A Pilot Study
Pandya, A. G., Nezafati, K. A., Ashe-Randolph, M., & Yalamanchili, R. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.807 · Cited by 13
Cited by
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Mitochondria at the neuronal presynapse in health and disease
Devine, M. J., & Kittler, J. T. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.170 · Cited by 615
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Dhuri, K., Bechtold, C., Quijano, E., Pham, H., Gupta, A., Vikram, A., & Bahal, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9062004 · Cited by 545
Scott, L. J. (2020) · Drugs · doi:10.1007/s40265-020-01269-0 · Cited by 420
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
Metadata
- Authors
- Bissell, D. M., Anderson, K. E., & Bonkovsky, H. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-08-31
- Volume
- 377
- Issue
- 9
- Pages
- 862-872
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4253599714
- Cited by
- 399
- References
- 49
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.